Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Now open for applications. This exciting new course runs from 6 to 8 January 2019 at the University of Oxford.

Are you aware of Experimental Medicine as an approach, but unsure how to begin your own study? Or are you supporting colleagues working on Experimental Medicine research projects, but unsure about the bigger picture?

The NIHR Oxford Health Biomedical Research Centre (NIHR OH BRC) is holding a new course in January 2019, the Oxford Short Course in Experimental Medicine for Mental Health (OxCEMM), for those with a basic understanding of experimental medicine who would like to develop a more comprehensive and practical grounding in this area.

Aimed at clinical and pre-clinical staff and trainees, pharmacists, basic scientists and allied health professionals, it’s an intensive two-and-a-half day course covering what you need to know to develop and conduct experimental medicine studies in mental health.  

With involvement from BRC researchers, from presentations and discussions, to small group exercises and research facility tours, it’s designed to be an interesting and useful programme.

Apply now via this link - limited places. Bursaries and accommodation available. Application deadline 5 October 2018.

Course brochure coming soon. In the meantime, for more information contact oxcemm@psych.ox.ac.uk

Similar stories

New WA Handley Chair of Psychiatry Appointed

Strategic Developments

Professor John Geddes has been appointed to the WA Handley Professorship of Psychiatry and will take up this post in November 2021.

Investigating New Treatment for Schizophrenia

Research Highlights Strategic Developments

A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim has been announced to investigate a new drug target for the treatment of schizophrenia.

Retirement of Professor Peter Brown

Strategic Developments

This month sees the retirement of Professor Peter Brown as Director of the Medical Research Council Brain Network Dynamics Unit at the University of Oxford.

The ALBA Declaration

Strategic Developments

Improving Equality, Diversity and Inclusiveness.

Recognition of Distinction Awards 2020

Awards and Honours Strategic Developments

It is a great pleasure to announce that a number of Neuroscience researchers have been successful in the recent assessment process for the conferment of the title of full Professor.

Ambitious Oxford initiative launched to address graduate under-representation

Strategic Developments

Oxford University and its colleges have announced a major new scholarship scheme for black graduate students as part of a programme to transform its graduate population by creating more funding opportunities for under-represented groups.